Related Experiment Video
Updated: Jul 26, 2026

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells
A Toulouse1, J Morin, P A Dion
1Centre de Recherche du CHUM, Pavillon Notre-Dame, 1560 Sherbrooke E., Montréal, Canada. mbem@musica.mcgill.ca
Abstract:
Retinoic acid receptor beta is the retinoid receptor most frequently associated with the growth suppressive effects of retinoic acid in various epithelial tumor-derived cell lines. In particular, it has been shown that transfection of RARbeta2 in epidermoid lung tumor cells could reduce their in vitro growth rate in the presence of retinoic acid and in vivo tumorigenicity. However, the question remained as to the isoform specificity of this effect. To investigate this, we transfected RARalpha1, RARbeta1 and RARbeta2 into the epidermoid lung cancer cell line Calu-1 and assessed the in vitro growth capacities of the transfected cells. The expression of the fetal RARbeta1 or overexpression of the ubiquitous RARalpha1 isoforms could not mimick the growth suppressive effect of RARbeta2. In addition we analyzed the expression of another RAR isoform, alpha2, in many tumor-derived lines and conclude from its expression pattern that RARalpha2 is unlikely to be involved in retinoic acid growth suppression of lung cancer. Overall our data suggest that the suppressive effect of RARbeta2 is isoform specific.
Insights
Retinoic acid receptor beta 2 (RARbeta2) specifically suppresses lung cancer cell growth. Other retinoic acid receptor isoforms, like RARalpha1 and RARbeta1, do not exhibit this same tumor-suppressive effect.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Retinoic acid receptor beta (RARbeta) is linked to growth suppression in epithelial tumors.
- RARbeta2 has previously shown potential in reducing lung tumor cell growth and tumorigenicity.
- The isoform specificity of this growth suppressive effect remained unclear.
Purpose of the Study:
- To investigate the isoform specificity of retinoic acid receptor (RAR)-mediated growth suppression in lung cancer.
- To determine if RARalpha1, RARbeta1, or RARbeta2 isoforms mediate the growth suppressive effects of retinoic acid.
Main Methods:
- Transfection of RARalpha1, RARbeta1, and RARbeta2 into the Calu-1 epidermoid lung cancer cell line.
- Assessment of in vitro growth capacities of transfected lung cancer cells.
- Analysis of RARalpha2 expression patterns in various tumor-derived cell lines.
Main Results:
- RARbeta2 transfection significantly reduced in vitro growth of Calu-1 cells in the presence of retinoic acid.
- Expression of RARbeta1 or RARalpha1 isoforms did not replicate the growth suppressive effect of RARbeta2.
- RARalpha2 expression patterns suggest it is not involved in retinoic acid-mediated growth suppression of lung cancer.
Conclusions:
- The growth suppressive effect of retinoic acid in lung cancer is RARbeta2 isoform specific.
- RARbeta1 and RARalpha1 isoforms do not mediate the observed tumor suppressive effects.
- RARbeta2 represents a specific therapeutic target for retinoic acid-driven lung cancer growth inhibition.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
Related Concept Videos
Negative Regulator Molecules
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: